Showing results (2261-2270 of 2,945) with videos related to

Sort By:
Pageof 295
Bioorganic & Medicinal Chemistry Letters|February 26, 2024
Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activityPraveen Kumar Tiwari, Sai Reddy Doda, Raghu Vannam, et al.
Statistics in Biosciences|January 10, 2022
A Statistical Method for Association Analysis of Cell Type CompositionsLicai Huang, Paul Little, Jeroen R Huyghe, et al.
Molecular and Cellular Endocrinology|December 22, 2015
Biological activity and in vivo half-life of pro-activin A in male ratsKatharine E Johnson, Yogeshwar Makanji, Peter Temple-Smith, et al.
Plos Neglected Tropical Diseases|July 6, 2022
"Then they prayed, they did nothing else, they just prayed for the boy and he was well": A qualitative investigation into the perceptions and behaviours surrounding snakebite and its management in rural communities of Kitui county, KenyaLeo Wood, Cecilia Ngari, Stanley Parkurito, et al.
Frontiers in Bioengineering and Biotechnology|September 26, 2019
Decellularized Adipose Tissue Hydrogel Promotes Bone Regeneration in Critical-Sized Mouse Femoral Defect ModelOmair A Mohiuddin, Brett Campbell, J Nick Poche, et al.
Thorax|October 12, 2012
The activin A antagonist follistatin inhibits asthmatic airway remodellingCharles Linton Hardy, Hong-An Nguyen, Rohimah Mohamud, et al.
Journal of Hepatology|February 12, 2025
A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASHStephen A Harrison, Naim Alkhouri, Grisell Ortiz-Lasanta, et al.
The Lancet. Gastroenterology & Hepatology|October 13, 2024
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trialRohit Loomba, Pierre Bedossa, Katharine Grimmer, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2021
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a studyKenneth Cusi, Naim Alkhouri, Stephen A Harrison, et al.
Scientific Reports|July 5, 2022
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognitionStefanie K Menzies, Charlotte A Dawson, Edouard Crittenden, et al.
Pageof 295